ArticleAmerican journal of translational research2026
Transarterial chemoembolization combined with PD-1 inhibitors for unresectable hepatocellular carcinoma: efficacy and hepatic safety at 4-week versus 6-week treatment intervals.
Tao Tian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.